| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparative study to evaluate the safety and immunogenicity of two lots of Haemophilus influenzae type-B conjugate vaccine manufactured at different scales
|
Hirve, Siddhivinayak
|
|
2011
|
29 |
33 |
p. 5363-5367
5 p.
|
artikel
|
| 2 |
Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial
|
Gudmundsdotter, L.
|
|
2011
|
29 |
33 |
p. 5558-5566
9 p.
|
artikel
|
| 3 |
A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae
|
Denoël, Philippe
|
|
2011
|
29 |
33 |
p. 5495-5501
7 p.
|
artikel
|
| 4 |
Bacterial etiology and serotypes of acute otitis media in Mexican children
|
Parra, Mercedes Macias
|
|
2011
|
29 |
33 |
p. 5544-5549
6 p.
|
artikel
|
| 5 |
Blinded, controlled field trial of two commercially available Mycoplasma bovis bacterin vaccines in veal calves
|
Soehnlen, Marty K.
|
|
2011
|
29 |
33 |
p. 5347-5354
8 p.
|
artikel
|
| 6 |
Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e
|
Park, Ki Seok
|
|
2011
|
29 |
33 |
p. 5481-5487
7 p.
|
artikel
|
| 7 |
Costs and impact of meningitis epidemics for the public health system in Burkina Faso
|
Colombini, Anaïs
|
|
2011
|
29 |
33 |
p. 5474-5480
7 p.
|
artikel
|
| 8 |
Development of a tailored vaccine against challenge with very virulent infectious bursal disease virus of chickens using reverse genetics
|
Gao, Li
|
|
2011
|
29 |
33 |
p. 5550-5557
8 p.
|
artikel
|
| 9 |
Development of live attenuated Bordetella pertussis strains expressing the universal influenza vaccine candidate M2e
|
Li, Rui
|
|
2011
|
29 |
33 |
p. 5502-5511
10 p.
|
artikel
|
| 10 |
Different patterns of expansion, contraction and memory differentiation of HIV-1 Gag-specific CD8 T cells elicited by adenovirus type 5 and modified vaccinia Ankara vaccines
|
Pillai, Vinod Kumar Bhaskara
|
|
2011
|
29 |
33 |
p. 5399-5406
8 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
2011
|
29 |
33 |
p. CO2-
1 p.
|
artikel
|
| 12 |
Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model
|
Zawadka, Monika
|
|
2011
|
29 |
33 |
p. 5488-5494
7 p.
|
artikel
|
| 13 |
Enhancement of immune response to an antigen delivered by vaccinia virus by displaying the antigen on the surface of intracellular mature virion
|
Embry, Addie
|
|
2011
|
29 |
33 |
p. 5331-5339
9 p.
|
artikel
|
| 14 |
Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells
|
Argilaguet, J.M.
|
|
2011
|
29 |
33 |
p. 5379-5385
7 p.
|
artikel
|
| 15 |
Escheriosome mediated cytosolic delivery of Candida albicans cytosolic proteins induces enhanced cytotoxic T lymphocyte response and protective immunity
|
Chauhan, A.
|
|
2011
|
29 |
33 |
p. 5424-5433
10 p.
|
artikel
|
| 16 |
Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate
|
Grund, Christian
|
|
2011
|
29 |
33 |
p. 5567-5573
7 p.
|
artikel
|
| 17 |
Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice
|
Li, Wen qing
|
|
2011
|
29 |
33 |
p. 5526-5533
8 p.
|
artikel
|
| 18 |
Lack of correlation between BCG-induced tuberculin skin test sensitisation and protective immunity in cattle
|
Whelan, A.O.
|
|
2011
|
29 |
33 |
p. 5453-5458
6 p.
|
artikel
|
| 19 |
Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits
|
Zhu, Hanping
|
|
2011
|
29 |
33 |
p. 5421-5423
3 p.
|
artikel
|
| 20 |
Nonclinical biodistribution, integration, and toxicology evaluations of an H5N1 pandemic influenza plasmid DNA vaccine formulated with Vaxfectin®
|
Doukas, John
|
|
2011
|
29 |
33 |
p. 5443-5452
10 p.
|
artikel
|
| 21 |
Pneumococcal conjugate vaccination at birth in a high-risk setting: No evidence for neonatal T-cell tolerance
|
van den Biggelaar, Anita H.J.
|
|
2011
|
29 |
33 |
p. 5414-5420
7 p.
|
artikel
|
| 22 |
Potential protective immunogenicity of recombinant Clostridium perfringens α–β2–β1 fusion toxin in mice, sows and cows
|
Zeng, Jin
|
|
2011
|
29 |
33 |
p. 5459-5466
8 p.
|
artikel
|
| 23 |
Reducing animal experimentation in foot-and-mouth disease vaccine potency tests
|
Reeve, Richard
|
|
2011
|
29 |
33 |
p. 5467-5473
7 p.
|
artikel
|
| 24 |
Single chain variable fragment antibodies against Shiga toxins isolated from a human antibody phage display library
|
Neri, Paola
|
|
2011
|
29 |
33 |
p. 5340-5346
7 p.
|
artikel
|
| 25 |
SLAM and DC-SIGN measles receptor polymorphisms and their impact on antibody and cytokine responses to measles vaccine
|
Clifford, Holly D.
|
|
2011
|
29 |
33 |
p. 5407-5413
7 p.
|
artikel
|
| 26 |
Surfactant protein C is an essential constituent for mucosal adjuvanticity of Surfacten, acting as an antigen delivery vehicle and inducing both local and systemic immunity
|
Mizuno, Dai
|
|
2011
|
29 |
33 |
p. 5368-5378
11 p.
|
artikel
|
| 27 |
The epidemiologic evidence underlying recommendations for use of pneumococcal polysaccharide vaccine among American Indian and Alaska Native populations
|
Said, Maria A.
|
|
2011
|
29 |
33 |
p. 5355-5362
8 p.
|
artikel
|
| 28 |
The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia—Over 22 years
|
Jacups, Susan P.
|
|
2011
|
29 |
33 |
p. 5386-5392
7 p.
|
artikel
|
| 29 |
The influence of molecular adjuvants in the cutaneous response to antigen after topical vaccination
|
Himes, Roy
|
|
2011
|
29 |
33 |
p. 5393-5398
6 p.
|
artikel
|
| 30 |
The optimal number of routine vaccines to order at health clinics in low or middle income countries
|
Rajgopal, Jayant
|
|
2011
|
29 |
33 |
p. 5512-5518
7 p.
|
artikel
|
| 31 |
Vaccination with epigenetically treated mesothelioma cells induces immunisation and blocks tumour growth
|
Guillot, Flora
|
|
2011
|
29 |
33 |
p. 5534-5543
10 p.
|
artikel
|
| 32 |
Vaccine adjuvant activity of 3M-052: An imidazoquinoline designed for local activity without systemic cytokine induction
|
Smirnov, Dmitri
|
|
2011
|
29 |
33 |
p. 5434-5442
9 p.
|
artikel
|
| 33 |
“Wait and see” vaccinating behaviour during a pandemic: A game theoretic analysis
|
Bhattacharyya, Samit
|
|
2011
|
29 |
33 |
p. 5519-5525
7 p.
|
artikel
|
Tijdschrift beschrijving